Korean Pharma Earnings Roundup: Dong-A, Green Cross Retain Leading Positions While Yuhan, LG Life, Hanmi Struggle

SEOUL - Of South Korea's five top pharmaceutical companies, Dong-A and Green Cross did relatively well in 2010, retaining their leading positions while Yuhan, LG Life Sciences and Hanmi failed to witness upward momentum amid a tightened government grip on the local pharmaceutical industry